Leqvio (inclisiran) is a prescription drug used to help treat certain types of high cholesterol. Leqvio comes in a prefilled syringe for injection under the skin. Leqvio contains the active drug ...
If I wasn’t sleeping, I was crying. I couldn’t think straight anymore. My adult daughter helped me realize Repatha was causing my depression. I slowly started feeling better after stopping the ...
MSD has fleshed out the results of phase 3 trials of its cholesterol-lowering, oral PCSK9 inhibitor, enlicitide decanoate, showing its efficacy was comparable to that of injectable alternatives. The ...
President Donald Trump announced Friday the latest reduced drug pricing deal made with a group of large pharmaceutical companies including Amgen, Gilead and Merck, doing so about four months after the ...
Dec 19 (Reuters) - The U.S. Food and Drug Administration said on Friday it has granted national priority vouchers to Merck's (MRK.N), opens new tab cholesterol pill and its cancer therapy, making them ...
BASEL (dpa-AFX) - President Donald Trump announced nine new agreements with major pharmaceutical companies aimed at lowering prescription drug prices for Americans. The White House said the agreements ...
Ellen and Tanya have both lost weight using GLP-1s but have had very different experiences when it comes to stopping the medication "It's like a switch that goes on and you're instantly starving." ...
President Donald Trump on Friday afternoon announced that nine major pharmaceutical companies have agreed to join his "most favored nation" pricing policy, bringing down the price of prescription ...
The International Fact-Checking Network (IFCN) leverages the expertise of its team, Poynter faculty, signatories and global partners to provide fact-checkers with the tools and resources they need to ...
Cosentyx (secukinumab) is a prescription drug used to treat certain types of arthritis and other conditions. The drug comes as a liquid solution inside single-use pens, syringes, and vials. It may be ...
President Donald Trump has just announced that nine new pharmaceutical companies- Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Roche's Genentech unit, Gilead, GSK, Merck, Novartis and ...